Recombinant Rat Stromal interaction molecule 1 (Stim1)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Rat Stromal Interaction Molecule 1 (STIM1)

Recombinant Rat STIM1 is a genetically engineered protein corresponding to the stromal interaction molecule 1, a critical calcium sensor in the endoplasmic reticulum (ER). It regulates store-operated calcium entry (SOCE) and interacts with plasma membrane ion channels, such as Orai1 and ATP-sensitive K⁺ (K<sub>ATP</sub>) channels. STIM1 plays roles in cellular signaling, immune function, and disease pathologies, including cardiac hypertrophy and cerebrovascular disorders .

Molecular Structure and Functional Domains

STIM1 contains:

  • EF-hand domains: Bind Ca²⁺ in the ER lumen, triggering conformational changes upon store depletion .

  • SAM domain: Stabilizes the protein’s inactive state; destabilization enables translocation to plasma membrane-associated membranes (PAMs) .

  • Cytosolic region: Interacts with Orai1 (via SOAR domain) and SUR1 (via NBF1 domain) .

DomainFunctionKey Interactions
EF-handCa²⁺ sensing in ER lumenOrai1, TMEM66/SARAF
SAM domainStructural stabilization; dissociates during Ca²⁺ depletionHydrophobic cleft formation
Cytosolic regionMediates channel activation (Orai1, K<sub>ATP</sub>)SUR1 NBF1, Kir6.2, Orai1

Regulation of SOCE and Calcium Signaling

STIM1 translocates to PAMs upon ER Ca²⁺ depletion, activating Orai1 channels to replenish Ca²⁺ stores. This mechanism is critical in β-cells for insulin secretion and in cardiomyocytes for hypertrophic signaling .

Interaction with K<sub>ATP</sub> Channels

STIM1 binds to the nucleotide-binding fold-1 (NBF1) of SUR1, enhancing K<sub>ATP</sub> channel activity. This interaction modulates β-cell membrane excitability and glucose-stimulated insulin secretion .

Role in Immune and Vascular Pathologies

  • Autoimmunity: STIM1-deficient mice exhibit spontaneous autoantibody production due to impaired T-cell help .

  • Cerebrovascular Disease: A truncating mutation in Stim1 causes microbleeds and stroke in SHR-A3 rats, linked to autoantibodies against cerebrovascular stress proteins .

Experimental Models

ModelKey FindingsSource
MIN6 β-cellsSTIM1 knockdown reduces SOCE and K<sub>ATP</sub> channel activity; reversed by adenoviral STIM1 rescue
SHR-A3 RatsStim1 mutation causes stroke; congenic Stim1-B2 substitution reduces cerebrovascular injury
Cardiomyocyte HypertrophySTIM1 silencing prevents pressure overload-induced hypertrophy in rats

Quantitative Data from Key Studies

ParameterValueExperimental ConditionSource
K<sub>ATP</sub> CurrentReduced by 50% in STIM1 knockdownThapsigargin-treated MIN6 cells
Cardiomyocyte SizeReduced by 30% with Stim1 silencingPressure-overloaded rats
Autoantibody LevelsDecreased in Stim1-B2 congenic ratsSHR-A3 with salt loading

Cardiac Hypertrophy

STIM1 is necessary and sufficient for hypertrophic responses in cardiomyocytes. Adenoviral Stim1 overexpression induces hypertrophy, while silencing prevents it in vivo .

Cerebrovascular Disease

The Stim1 mutation in SHR-A3 rats causes:

  • Microbleeds and major hemorrhages (absent in Stim1-B2 congenic rats).

  • Autoantibodies against cerebrovascular stress proteins (e.g., GFAP, MBP) .

Detection and Quantification Methods

MethodApplicationSensitivitySource
Western BlotSTIM1 protein detection in lysatesEndogenous levels
ELISAQuantification of STIM1 in rat samplesHigh specificity
ImmunoprecipitationMapping STIM1-SUR1 interactionsNBF1 domain binding

Product Specs

Form
Lyophilized powder
Note: We will prioritize shipping the format currently in stock. However, if you have a specific format requirement, please indicate it in your order notes. We will fulfill your request if possible.
Lead Time
Delivery time may vary depending on the purchasing method or location. Please contact your local distributors for specific delivery information.
Note: All our proteins are shipped with standard blue ice packs. If you require dry ice shipping, please notify us in advance as additional fees will apply.
Notes
Repeated freezing and thawing is not recommended. Store working aliquots at 4°C for up to one week.
Reconstitution
We recommend briefly centrifuging the vial before opening to ensure the contents settle to the bottom. Reconstitute the protein in deionized sterile water to a concentration of 0.1-1.0 mg/mL. We recommend adding 5-50% glycerol (final concentration) and aliquoting for long-term storage at -20°C/-80°C. Our default glycerol concentration is 50%. Customers can use this as a reference.
Shelf Life
The shelf life depends on various factors including storage conditions, buffer composition, temperature, and the protein's inherent stability.
Generally, liquid forms have a shelf life of 6 months at -20°C/-80°C. Lyophilized forms have a shelf life of 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type will be determined during the manufacturing process.
The tag type will be determined during the production process. If you have a specific tag type requirement, please inform us, and we will prioritize developing the specified tag.
Synonyms
Stim1; Sim; Stromal interaction molecule 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
23-685
Protein Length
Full Length of Mature Protein
Species
Rattus norvegicus (Rat)
Target Names
Target Protein Sequence
LSHSHSEKNTGASSGATSEESTEAEFCRIDKPLCHSEDEKLSFEAVRNIHKLMDDDANGDVDVEESDEFLREDLNYHDPTVKHSTFHGEDKLISVEDLWKAWKASEVYNWTVDEVIQWLITYVELPQYEETFRKLQLTGHAMPRLAVTNTTMTGTVLKMTDRSHRQKLQLKALDTVLFGPPLLTRHNHLKDFMLVVSIVIGVGGCWFAYIQNRYSKEHMKKMMKDLEGLHRAEQSLHDLQERLHKAQEEHRTVEVEKVHLEKKLRDEINLAKQEAQRLKELREGTENERSRQKYAEEELEQVREALRKAEKELESHSSWYAPEALQKWLQLTHEVEVQYYNIKKQNAERQLLVAKEGAEKIKKKRNTLFGTFHVAHSSSLDDVDHKILTAKQALSEVTAALRERLHRWQQIEILCGFQIVNNPGIHSLVAALNIDPSWMGSTRPNPAHFIMTDDVDDMDEEIVSPLSMQSPSLQSSVRQRLTEPQHGLGSQRDLTHSDSESSLHTSDRQRVAPKPPQMGRAADEALNATSSNGSHRLIEGVHPGSLVEKLPDSPALAKKTILALNHGLDKAHSLMELNPSVPPGGSPLLDSSHSHSPSSPDPDTPSPVGDSRALQGSRNTRIPHLAGKKAMAEEDNGSIGEETDSSPGRKKFPLKIFKKPLKK
Uniprot No.

Target Background

Function
STIM1 plays a crucial role in mediating store-operated Ca(2+) entry (SOCE), a Ca(2+) influx that occurs following depletion of intracellular Ca(2+) stores. It acts as a Ca(2+) sensor in the endoplasmic reticulum through its EF-hand domain. When Ca(2+) levels are depleted, STIM1 translocates from the endoplasmic reticulum to the plasma membrane, where it activates the Ca(2+) release-activated Ca(2+) (CRAC) channel subunit ORAI1. STIM1 is also involved in enamel formation. It becomes activated upon interaction with STIMATE, leading to a conformational switch in STIM1.
Gene References Into Functions
  1. Suppression of STIM1 reduced intracellular calcium levels and attenuated hypoxia/reoxygenation-induced apoptosis in H9C2 cardiomyocytes. PMID: 29089467
  2. Downregulation of miR-223 by phenylephrine contributed to the increase of STIM1, which in turn induced cardiac hypertrophy. PMID: 29110214
  3. STIM1 may play a significant role in the pathogenesis of alcoholic liver disease. PMID: 29704510
  4. The function of STIM1 in the regulation of store-operated Ca(2+)-entry in astrocytes PMID: 27237974
  5. Sub-lethal levels of proteasome inhibition reduce store-operated calcium entry and promote autophagy-mediated degradation of STIM1 and STIM2. PMID: 26960935
  6. STIM1 binding to phospholamban contributes to the regulation of SERCA2a activity in the steady state and rate of SR Ca(2+) leak, and these actions are independent of store-operated Ca(2+) entry, a process absent in normal heart cells. PMID: 26261328
  7. This study investigated the effect of STIM1 knockdown on the proliferation and migration of endothelial progenitor cells (EPCs) after vascular injury and its underlying mechanism. PMID: 25063063
  8. Knockdown of STIM1 blocked degradation of Sp4, whereas expression of constitutively active STIM1 decreased Sp4 abundance under depolarizing conditions. PMID: 24894994
  9. Our findings suggest that Stim1 is a strong candidate gene responsible for the exaggerated sympathetic response to stress in SHRSP. PMID: 24736434
  10. This study demonstrated that inhibition of Stim1 expression and decreased the intracellular calcium concentration in neurons. PMID: 24509424
  11. Experimental subarachnoid hemorrhage significantly increased mRNA and protein expressions of STIM1 in rats. PMID: 23542055
  12. Silencing of STIM1 significantly decreases cellular proliferation and delayed cell cycle progression induced by hypoxia. PMID: 23289723
  13. These results indicate enhanced STIM1 expression due to diffuse axonal injury. PMID: 23261659
  14. The overexpression of STIM1 increased by twofold the Ca(2+) influx evoked by thrombin, while knockdown of endogenous STIM1 significantly decreased this Ca(2+) influx. PMID: 22944608
  15. Modification of STIM1 by O-linked N-acetylglucosamine (O-GlcNAc) attenuates store-operated calcium entry in neonatal cardiomyocytes. PMID: 22992728
  16. STIM1 is essential for correct growth cone navigation and plays multiple roles in growth cone motility, including activation of store-operated calcium entry (SOCE). PMID: 22712562
  17. By controlling a previously unrecognized sarcolemmal current, STIM1 promotes cardiac hypertrophy. PMID: 21810664
  18. STIM1 is a potent regulator of cell proliferation and migration in rat endothelial progenitor cells (EPCs) and may play a significant role in the biological properties of EPCs. PMID: 20599714
  19. HGF-induced EPC proliferation is mediated partly via activation of STIM1. PMID: 20404049
  20. This proposes that STIM1 functions as the missing link between Ca2+ store depletion and store-operated calcium influx, serving as a Ca2+ sensor that translocates upon store depletion to the plasma membrane to activate CRAC channels. PMID: 16208375
  21. Suppression of store-operated channels function by Orai1 overexpression likely reflects a required stoichiometry between STIM1 and Orai1. PMID: 16766533
  22. Knockdown of STIM1 (stromal interaction molecule type 1) by siRNA also resulted in a significant reduction (approximately 80% at 72 h post-transfection) of the I(SOC) amplitude. PMID: 17432954
  23. Differences in STIM1 and TRPC expression in proximal and distal pulmonary arterial smooth muscle are associated with differences in Ca2+ responses to hypoxia. ( PMID: 18424621
  24. Knockdown of Stim1 inhibits endothelial proliferation and causes cell cycle arrest at S and G2/M phase. PMID: 18845811
  25. Results suggest STIM1 plays a critical role in neointimal formation in a rat model of vascular injury. PMID: 19052075
  26. STIM1 appears as a major regulator of in vitro and in vivo vascular smooth muscle cell proliferation, representing a novel and original pharmacological target for prominent vascular proliferative diseases. PMID: 19107116
  27. STIM1 was quantitatively more important than STIM2 in activation of store-operated channels in rat distal pulmonary arterial smooth muscle cells. PMID: 19395668

Show More

Hide All

Database Links
Subcellular Location
Cell membrane; Single-pass type I membrane protein. Endoplasmic reticulum membrane; Single-pass type I membrane protein. Sarcoplasmic reticulum. Cytoplasm, cytoskeleton.

Q&A

What is the fundamental role of STIM1 in cellular calcium signaling?

STIM1 functions as a critical endoplasmic reticulum (ER) Ca²⁺ sensor that regulates store-operated Ca²⁺ entry (SOCE). After depletion of ER Ca²⁺ stores, STIM1 undergoes conformational changes that enable it to interact with and activate Orai channels in the plasma membrane. This interaction facilitates Ca²⁺ influx into the cell, a process essential for numerous cellular functions . In addition to its canonical role in SOCE, STIM1 has been shown to regulate other ion channels and participate in various signaling pathways independent of store depletion .

How does the domain structure of STIM1 contribute to its function?

STIM1 contains several functional domains that work in concert to mediate its sensing and signaling capabilities:

  • A luminal EF-hand domain that acts as the Ca²⁺ sensor in the ER

  • A transmembrane domain anchoring STIM1 in the ER membrane

  • Cytosolic coiled-coil domains (including CC1) that mediate protein-protein interactions

  • The CRAC activation domain (CAD) that directly binds to and activates Orai channels

In resting cells with replete Ca²⁺ stores, the CC1 domain interacts with CAD in a domain-swapped configuration, sequestering the Orai-binding region near the ER membrane. Following ER Ca²⁺ depletion, this inhibitory interaction is disrupted, allowing CC1 domains to pair closely along their length and propel CAD toward the plasma membrane to engage Orai channels and initiate SOCE .

What are the most effective methods for evaluating STIM1 function in primary cell cultures?

When investigating STIM1 function in primary cells, researchers should consider implementing multiple complementary approaches:

  • Calcium imaging techniques: Fura-2 or other ratiometric Ca²⁺ indicators can be used to monitor changes in intracellular Ca²⁺ levels following store depletion, often achieved using thapsigargin (a SERCA inhibitor) .

  • Genetic manipulation strategies:

    • RNA interference (shRNA or siRNA) for STIM1 knockdown

    • Viral gene shuttle vectors (e.g., adenovirus) for STIM1 overexpression or rescue experiments

    • CRISPR/Cas9 for generating STIM1-knockout cells

  • Protein-protein interaction studies: Co-immunoprecipitation assays can reveal STIM1's binding partners, as demonstrated in studies showing STIM1 interaction with SUR1 and NBF1 .

  • Super-resolution microscopy: Techniques such as TIRF-mode GSDIM (ground state depletion microscopy followed by individual molecule return) can visualize STIM1 cluster formation and translocation to plasma membrane-proximal regions .

How can researchers effectively distinguish between SOCE-dependent and SOCE-independent functions of STIM1?

Distinguishing between these functions requires strategic experimental design:

  • Pharmacological approach: Utilize specific SOCE inhibitors (e.g., SKF-96365, 2-APB) alongside STIM1 manipulation to determine whether observed effects persist when SOCE is blocked .

  • Mutation studies: Express STIM1 mutants that specifically disrupt SOCE (e.g., STIM1 EF-hand mutants that constitutively activate SOCE) versus mutations affecting other protein interactions.

  • Temporal analysis: Monitor rapid versus delayed responses following STIM1 manipulation, as SOCE-independent functions may follow different kinetics.

  • Context-specific experiments: Compare STIM1 functions in cell types with robust SOCE (e.g., immune cells) versus those with minimal SOCE (e.g., contractile VSMCs, which exhibit virtually undetectable SOCE despite STIM1 expression) .

How does STIM1 contribute to cardiac hypertrophy, and what experimental models best demonstrate this relationship?

STIM1 plays a crucial role in cardiac hypertrophy through Ca²⁺-dependent signaling pathways. Research has established that STIM1 is both sufficient and necessary for cardiomyocyte hypertrophy in vitro and in the adult heart in vivo .

Experimental models that effectively demonstrate this relationship include:

  • In vitro cardiomyocyte models:

    • Neonatal rat ventricular myocytes treated with hypertrophic stimuli (e.g., angiotensin II, phenylephrine)

    • Adult cardiomyocytes with STIM1 overexpression or knockdown

  • In vivo models:

    • Pressure overload-induced hypertrophy via transverse aortic constriction (TAC)

    • STIM1 gene silencing by viral gene transfer in adult rats, which has been shown to protect against pressure overload-induced cardiac hypertrophy

    • Cardiac-specific STIM1 knockout or overexpression mouse models

  • Key measurements:

    • Heart weight to body weight ratio

    • Cardiomyocyte cross-sectional area

    • Expression of hypertrophic marker genes (ANP, BNP, β-MHC)

    • Echocardiographic assessment of cardiac function and wall thickness

    • Ca²⁺ signaling dynamics in isolated cardiomyocytes

What mechanisms underlie STIM1-dependent regulation of vascular smooth muscle cell (VSMC) contractility?

STIM1 regulates VSMC contractility through mechanisms that extend beyond its canonical role in SOCE. In contractile VSMCs, STIM1:

  • Maintains SR-PM junctional integrity: STIM1 is crucial for fostering sarcoplasmic reticulum-plasma membrane (SR-PM) junctions, specialized regions where the SR and PM are closely apposed. Stim1 knockout in VSMCs significantly reduces the number and sizes of SR/PM coupling sites .

  • Facilitates functional coupling: STIM1 enables functional coupling between SR Ca²⁺ release sites and Ca²⁺-activated ion channels on the PM (e.g., BK and TRPM4 channels) in a manner independent of Orai1, Ca²⁺ store depletion, and SOCE .

  • Regulates ion channel architecture: Stim1 knockout alters the nanoscale architecture of ion channels in Ca²⁺-signaling complexes, transforming the properties of Ca²⁺ sparks and diminishing BK and TRPM4 channel activity under physiological conditions .

  • Influences vascular tone: Resistance arteries isolated from Stim1-smKO mice (smooth muscle-specific knockout) exhibit blunted responses to vasoconstrictor stimuli, and animals become hypotensive following acute knockout of Stim1 in smooth muscle .

These findings highlight STIM1's role as a structural scaffold that organizes ion channel complexes at SR-PM junctions, which is essential for vascular function independent of its role in SOCE.

How does STIM1 contribute to neuronal function and what are the implications for neurodegenerative disease research?

STIM1 plays multiple important roles in neuronal function:

  • Regulation of glutamate receptor signaling: STIM1 physically binds to GluA1/GluA2 AMPA receptors and controls AMPA-induced Ca²⁺ entry, suggesting direct modulation of excitatory neurotransmission .

  • Synaptic plasticity: STIM1 overexpression in neurons reduces long-term depression in hippocampal slices, indicating its involvement in activity-dependent synaptic modifications .

  • Behavioral effects: Transgenic mice with neuronal STIM1 overexpression show decreased anxiety-like behavior and improved contextual learning, supporting STIM1's role in memory formation .

  • Dendritic spine maintenance: Evidence suggests STIM1 is involved in the preservation of dendritic spines required for long-term potentiation, potentially through modulation of L-type voltage-operated calcium channels (VOCCs) .

Research implications for neurodegenerative diseases:

  • STIM1 dysfunction may contribute to synaptic loss and cognitive decline in conditions like Alzheimer's disease

  • Therapeutic strategies targeting STIM1-dependent pathways might preserve neuronal connectivity and function

  • STIM1 could serve as a biomarker for synaptic health in neurodegenerative conditions

What methodological approaches are most effective for studying STIM1 dynamics in neurons?

Investigating STIM1 dynamics in neurons requires specialized approaches:

  • Advanced imaging techniques:

    • Live-cell imaging with fluorescently tagged STIM1 to track translocation in response to stimuli

    • Super-resolution microscopy to visualize STIM1 clustering at ER-PM junctions

    • FRET-based approaches to detect conformational changes and protein interactions

  • Electrophysiological methods:

    • Patch-clamp recordings to measure SOCE currents and effects on neuronal excitability

    • Field potential recordings in brain slices to assess effects on synaptic transmission

    • Combined calcium imaging and electrophysiology to correlate STIM1 function with neuronal activity

  • Genetic manipulation in neuronal systems:

    • AAV-mediated STIM1 overexpression or knockdown in specific neuronal populations

    • Conditional knockout models with neuronal or brain region specificity

    • STIM1 mutant constructs to isolate specific functional domains

  • Behavioral paradigms:

    • Learning and memory tests in STIM1-modified animal models

    • Anxiety and exploratory behavior assessments

    • Cognitive flexibility and adaptation tasks

How does STIM1 regulate pancreatic β-cell function and insulin secretion?

STIM1 plays multifaceted roles in pancreatic β-cell function:

  • Regulation of ATP-sensitive K⁺ (KATP) channels: STIM1 physically interacts with the sulfonylurea receptor 1 (SUR1) subunit of KATP channels, specifically binding to the nucleotide binding fold-1 (NBF1) region. This interaction may directly modulate channel function, as evidenced by the finding that STIM1 knockdown in MIN6 β-cells inhibits KATP channel activation .

  • Control of calcium signaling: Beyond its canonical role in SOCE, STIM1 influences multiple aspects of β-cell Ca²⁺ dynamics, which are essential for glucose-stimulated insulin secretion.

  • Membrane excitability: By regulating both SOCE and KATP channels, STIM1 participates in the control of β-cell membrane excitability, a key determinant of insulin secretion patterns .

The interaction between STIM1 and SUR1 was confirmed through co-immunoprecipitation studies. This binding was enhanced by poly-lysine, suggesting that electrostatic interactions play a role in STIM1-SUR1 binding .

What experimental approaches can effectively demonstrate the relationship between STIM1 and KATP channel function?

To investigate STIM1-KATP channel interactions, researchers should consider:

  • Molecular interaction studies:

    • Co-immunoprecipitation assays using antibodies against STIM1, SUR1, or tags (e.g., FLAG) as demonstrated with mouse islet protein extracts and transfected HEK293T cells

    • Domain mapping experiments to identify specific interaction sites, such as those that revealed STIM1 binding to the NBF1 region of SUR1

    • Proximity ligation assays to visualize protein interactions in intact cells

  • Functional assessments:

    • Patch-clamp electrophysiology to directly measure KATP channel activity following STIM1 manipulation

    • Membrane potential measurements using fluorescent indicators

    • Ca²⁺ imaging to correlate STIM1 function with β-cell Ca²⁺ oscillations

  • Genetic manipulation strategies:

    • RNA interference to reduce STIM1 expression, with reversal by adenoviral gene transfer expressing human STIM1 to confirm specificity

    • Expression of STIM1 mutants with altered ER Ca²⁺ sensing or protein interaction capabilities

    • CRISPR/Cas9-mediated genome editing for complete STIM1 knockout

  • Pharmacological approaches:

    • KATP channel modulators (e.g., diazoxide, glibenclamide) in combination with STIM1 manipulation

    • SOCE inhibitors to distinguish SOCE-dependent from SOCE-independent effects on KATP function

How should researchers address potential contradictions in STIM1 function across different tissue types?

When confronting seemingly contradictory findings regarding STIM1 function across tissues, consider these methodological approaches:

  • Tissue-specific expression profiling:

    • Quantify not only STIM1 expression levels but also its splice variants and post-translational modifications

    • Examine the expression of STIM1-interacting partners (Orai1-3, SUR1, etc.) that may influence function

    • Consider the ratio of STIM1 to STIM2, as their relative expression may determine net functional outcomes

  • Context-dependent functional analysis:

    • Design parallel experiments in different cell types under identical conditions

    • Systematically vary extracellular and intracellular Ca²⁺ concentrations to test sensitivity to Ca²⁺ store depletion

    • Compare acute versus chronic STIM1 manipulation to distinguish immediate from adaptive responses

  • Cell state considerations:

    • In VSMCs, for example, STIM1 function differs dramatically between proliferative and contractile phenotypes, with robust SOCE observed only in proliferative VSMCs

    • Assess cellular differentiation state when interpreting STIM1 function

    • Consider metabolic state, as energy availability may influence STIM1-dependent processes

  • Methodological reconciliation:

    • Directly compare in vitro versus in vivo findings

    • Validate key findings using multiple independent techniques

    • Consider species differences when comparing rodent and human studies

What are the critical considerations for generating and validating recombinant rat STIM1 constructs for research applications?

When developing recombinant rat STIM1 constructs, researchers should address:

  • Design considerations:

    • Sequence verification against rat genome databases to ensure accuracy

    • Codon optimization for expression system (bacterial, insect, mammalian)

    • Strategic placement of tags (His, FLAG, fluorescent proteins) to minimize functional interference

    • Inclusion of cleavable tags if native protein is desired for downstream applications

  • Expression systems:

    • Bacterial systems for protein domains lacking post-translational modifications

    • Mammalian expression for fully glycosylated, properly folded STIM1

    • Consider that N-glycosylation mutations (N131Q/N171Q) prevent cell surface expression

  • Functional validation:

    • Ca²⁺ imaging to confirm proper ER Ca²⁺ sensing and SOCE activation

    • Microscopy to verify appropriate subcellular localization and translocation

    • Co-immunoprecipitation to confirm expected protein interactions

    • Rescue experiments in STIM1-depleted cells to demonstrate functionality

  • Common challenges and solutions:

    • Protein instability: Consider expressing functional domains rather than full-length protein

    • Aberrant trafficking: Verify ER localization through co-localization with ER markers

    • Dominant negative effects: Titrate expression levels carefully when overexpressing

    • Species differences: Be aware that rat STIM1 may have subtly different properties than human or mouse orthologs

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.